136 related articles for article (PubMed ID: 14722326)
1. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
Billman GE; Houle MS; Englert HC; Gögelein H
J Pharmacol Exp Ther; 2004 Apr; 309(1):182-92. PubMed ID: 14722326
[TBL] [Abstract][Full Text] [Related]
2. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
Billman GE; Englert HC; Schölkens BA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
[TBL] [Abstract][Full Text] [Related]
3. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells.
Gögelein H; Hartung J; Englert HC; Schölkens BA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1453-64. PubMed ID: 9732411
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
Weyermann A; Vollert H; Busch AE; Bleich M; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):374-81. PubMed ID: 15024553
[TBL] [Abstract][Full Text] [Related]
6. HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats.
Wirth KJ; Klaus E; Englert HG; Schölkens BA; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):295-300. PubMed ID: 10543431
[TBL] [Abstract][Full Text] [Related]
7. K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs.
Wirth KJ; Uhde J; Rosenstein B; Englert HC; Gögelein H; Schölkens BA; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):155-60. PubMed ID: 10685870
[TBL] [Abstract][Full Text] [Related]
8. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
9. Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureas.
Englert HC; Gerlach U; Goegelein H; Hartung J; Heitsch H; Mania D; Scheidler S
J Med Chem; 2001 Mar; 44(7):1085-98. PubMed ID: 11297455
[TBL] [Abstract][Full Text] [Related]
10. Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
Gögelein H; Ruetten H; Albus U; Englert HC; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):33-41. PubMed ID: 11485036
[TBL] [Abstract][Full Text] [Related]
11. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
[TBL] [Abstract][Full Text] [Related]
12. Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion.
Dhein S; Pejman P; Krüsemann K
Eur J Pharmacol; 2000 Jun; 398(2):273-84. PubMed ID: 10854840
[TBL] [Abstract][Full Text] [Related]
13. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
[TBL] [Abstract][Full Text] [Related]
14. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S; Baczkó I; Leprán I
Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IKs channels by HMR 1556.
Gögelein H; Brüggemann A; Gerlach U; Brendel J; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):480-8. PubMed ID: 11138839
[TBL] [Abstract][Full Text] [Related]
16. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
Fischbach PS; White A; Barrett TD; Lucchesi BR
J Pharmacol Exp Ther; 2004 May; 309(2):554-9. PubMed ID: 14747611
[TBL] [Abstract][Full Text] [Related]
17. Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
Rainbow RD; Norman RI; Hudman D; Davies NW; Standen NB
J Mol Cell Cardiol; 2005 Oct; 39(4):637-46. PubMed ID: 16099467
[TBL] [Abstract][Full Text] [Related]
18. Cardioselective sulfonylthiourea HMR 1098 blocks mitochondrial uncoupling induced by a KATP channel opener, P-1075, in beating rat hearts.
Jilkina O; Kuzio B; Grover GJ; Kupriyanov VV
Biochim Biophys Acta; 2003 Jul; 1638(2):121-8. PubMed ID: 12853117
[TBL] [Abstract][Full Text] [Related]
19. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs.
Billman GE; Avendano CE; Halliwill JR; Burroughs JM
J Cardiovasc Pharmacol; 1993 Feb; 21(2):197-204. PubMed ID: 7679152
[TBL] [Abstract][Full Text] [Related]
20. ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion.
Wirth KJ; Rosenstein B; Uhde J; Englert HC; Busch AE; Schölkens BA
J Pharmacol Exp Ther; 1999 Nov; 291(2):474-81. PubMed ID: 10525061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
